News

March 14, 2019March 15, 2019

Synchronizing Finger Taps to Regular Beats Improves Gait of Parkinson’s Patients, Study Suggests

News

Parkinson’s disease patients improved their gait after undergoing training in which they tapped their fingers in synchrony to regular beats set at a faster pace than their walking speed, ... Read more

March 14, 2019March 19, 2019

AXO-Lenti-PD Gene Therapy Shows Benefits in 2 Advanced Parkinson’s Patients in Phase 1/2 Trial

News

One-time treatment with the gene therapy candidate AXO-Lenti-PD led to improved motor function and was well-tolerated after three months in two patients with advanced Parkinson’s disease, according to early ... Read more

March 13, 2019March 13, 2019

Anavex 2-73 Trial Recruitment Reaches Halfway Mark

News

A Phase 2 trial evaluating the efficacy and safety of investigational Anavex 2-73 as a treatment for Parkinson’s disease dementia has recruited half of its targeted patients, the therapy’s developer, Anavex Life Sciences, has ... Read more

March 13, 2019March 20, 2019

Study Cites Factors Associated With Sleep Benefit In Parkinson’s Disease

News

Parkinson’s patients who have had the disease for a long time, who do not sleep very efficiently, and have higher motor impairment are more likely to experience sleep benefit — ... Read more

March 12, 2019March 15, 2019

Seelos to Test Potential Parkinson’s Treatment Targeting Alpha-synuclein Clumps

News

Seelos Therapeutics has acquired an exclusive license to further develop a treatment approach called SLS-007 for Parkinson’s disease which is intended to lessen the aggregation of alpha-synuclein protein. The therapeutic ... Read more

March 12, 2019March 12, 2019

New Strategy Targets Parkinson’s by Improving Dopamine Metabolism, Study Reports

News

In contrast to what was previously believed, a key protein implicated in Parkinson’s disease — called Nurr1 — can be modulated using naturally existing molecules or engineered small molecules to ... Read more

March 11, 2019March 13, 2019

Repurposed Therapies, New Compounds to Be Tested to Block Brain Inflammation in Parkinson’s

News

Researchers in Australia are planning to test therapies already being used in other inflammatory conditions, as well as new compounds, for their potential to block brain inflammation and halt ... Read more

March 11, 2019March 11, 2019

Top Parkinson’s Experts Join Inhibikase Therapeutics Scientific Advisory Board

News

To further support its quest to advance a new therapy for Parkinson’s disease and related disorders, Inhibikase Therapeutics has added three leading researchers to its Scientific Advisory Board (SAB). ... Read more

March 8, 2019March 8, 2019

Scientist Lands $5M Grant to Study Link Between Pesticides, Smell and Parkinson’s

News

The National Institutes of Health (NIH) has granted a Michigan State University scientist $5 million to study a possible link between pesticides, a diminished sense of smell, and early symptoms ... Read more

March 8, 2019March 8, 2019

Freedom of Movement May Be Misinterpreted as Balance Instability, Parkinson’s Study Suggests

News

Antiparkinsonian medicines may allow patients with mild to moderate Parkinson’s disease to experience freedom of movement, which could be confused with balance issues if measured by traditional postural stability ... Read more

Pin It on Pinterest